Unco therapeutics welcomes dr. surbhi chitnis

Unco Therapeutics is pleased to welcome Dr. Surbhi Chitnis as Co-Founder & Founding Scientist,  where she will help shape and drive the company’s early therapeutic strategy. Surbhi brings deep experience in small-molecule drug discovery and a strong focus on translating scientific insights into viable therapeutic programs. She joins from New York University, where she contributed to early-stage discovery efforts using structure-informed approaches to guide decision-making. She earned her Ph.D. in Medicinal Chemistry from the University at Buffalo, where her work advanced next-generation targeted cancer therapies through innovative kinase inhibitor design and optimization. At Unco, she will play a central role in defining scientific direction and advancing differentiated therapeutic programs from concept through early validation.